Researchers from the University of Gothenburg, in collaboration with colleagues from University of Glasgow, present data that the drug Entresto (sacubitril/valsartan) which is commonly used for the treatment of cardiac failure leads to a marked reduction in plasma Aβ ratio, a candidate blood test for Alzheimer’s disease (AD).
FDA priority review advances Atara’s tabelecleucel for viral infection – Pharmaceutical Technology
Tabelecleucel is an allogenic, T cell immunotherapy designed to identify and eliminate EBV-infected cells. Credits: FrentaN/Shutterstock.com Atara Biotherapeutics has announced that the US Food and
July 19, 2024